Original Research
Accepted on 28 Aug 2025
Blinatumomab Demonstrates MRD Eradication in MRD-Positive/Chemotherapy-Delayed Pediatric B-ALL and High Response in Relapsed/Refractory Cases: A Multicenter Cohort Study
in Cancer Immunity and Immunotherapy